These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15840218)

  • 21. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M; Sureda A; Martino R; Madoz P; García J; Brunet S
    Haematologica; 1998 May; 83(5):428-31. PubMed ID: 9658727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermediate-dose CY and G-CSF more efficiently mobilize adequate numbers of PBSC for tandem autologous PBSC transplantation compared with low-dose CY in patients with multiple myeloma.
    Hiwase DK; Bollard G; Hiwase S; Bailey M; Muirhead J; Schwarer AP
    Cytotherapy; 2007; 9(6):539-47. PubMed ID: 17882718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Both autologous bone marrow mononuclear cell and peripheral blood progenitor cell therapies similarly improve ischaemia in patients with diabetic foot in comparison with control treatment.
    Dubsky M; Jirkovska A; Bem R; Fejfarova V; Pagacova L; Sixta B; Varga M; Langkramer S; Sykova E; Jude EB
    Diabetes Metab Res Rev; 2013 Jul; 29(5):369-76. PubMed ID: 23390092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flt3 ligand and thrombopoietin serum levels during peripheral blood stem cell mobilization with chemotherapy and recombinant human glycosylated granulocyte colony-stimulating factor (rhu-G-CSF, lenograstim) and after high-dose chemotherapy.
    Bojko P; Pawloski D; Stellberg W; Schröder JK; Seeber S
    Ann Hematol; 2002 Sep; 81(9):522-8. PubMed ID: 12373354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
    Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
    Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term clinical outcomes for patients with lower limb ischemia implanted with G-CSF-mobilized autologous peripheral blood mononuclear cells.
    Horie T; Onodera R; Akamastu M; Ichikawa Y; Hoshino J; Kaneko E; Iwashita C; Ishida A; Tsukamoto T; Teramukai S; Fukushima M; Kawamura A;
    Atherosclerosis; 2010 Feb; 208(2):461-6. PubMed ID: 19720375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse events during treatment of critical limb ischemia with autologous peripheral blood mononuclear cell implant.
    Jonsson TB; Larzon T; Arfvidsson B; Tidefelt U; Axelsson CG; Jurstrand M; Norgren L
    Int Angiol; 2012 Feb; 31(1):77-84. PubMed ID: 22330628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy.
    Spitzer G; Adkins D; Mathews M; Velasquez W; Bowers C; Dunphy F; Kronmueller N; Niemeyer R; McIntyre W; Petruska P
    Bone Marrow Transplant; 1997 Dec; 20(11):921-30. PubMed ID: 9422470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
    Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mobilization of autologous peripheral blood stem cells by combined chemotherapy and rhG-CSF].
    Shi H; Gu X; Zhu L
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):159-61. PubMed ID: 11783025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous peripheral blood stem cell transplantation to treat thromboangiitis obliterans: preliminary results.
    Wan J; Yang Y; Ma ZH; Sun Y; Liu YQ; Li GJ; Zhang GM
    Eur Rev Med Pharmacol Sci; 2016; 20(3):509-13. PubMed ID: 26914127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.
    Kawamoto A; Katayama M; Handa N; Kinoshita M; Takano H; Horii M; Sadamoto K; Yokoyama A; Yamanaka T; Onodera R; Kuroda A; Baba R; Kaneko Y; Tsukie T; Kurimoto Y; Okada Y; Kihara Y; Morioka S; Fukushima M; Asahara T
    Stem Cells; 2009 Nov; 27(11):2857-64. PubMed ID: 19711453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation.
    Kawamura A; Horie T; Tsuda I; Ikeda A; Egawa H; Imamura E; Iida J; Sakata H; Tamaki T; Kukita K; Meguro J; Yonekawa M; Kasai M
    Ther Apher Dial; 2005 Feb; 9(1):59-63. PubMed ID: 15828908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic angiogenesis by autologous transplantation of bone-marrow cells in a patient with progressive limb ischemia due to arteriosclerosis obliterans: a case report].
    Hasebe H; Osada M; Kodama Y; Fujioka D; Sano K; Nakamura T; Mitsumori T; Nakamura K; Kitta Y; Ichiki Y; Obata J; Kawabata K; Yanagi M; Sano S; Takano H; Umetani K; Kugiyama K
    J Cardiol; 2004 Apr; 43(4):179-83. PubMed ID: 15125382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction for intracoronary cell infusion.
    Chang SA; Kang HJ; Lee HY; Kim KH; Hur J; Han KS; Park YB; Kim HS
    Heart; 2009 Aug; 95(16):1326-30. PubMed ID: 19460773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilised peripheral mononuclear cells in diabetic patients with critical limb ischaemia.
    Mohammadzadeh L; Samedanifard SH; Keshavarzi A; Alimoghaddam K; Larijani B; Ghavamzadeh A; Ahmadi AS; Shojaeifard A; Ostadali MR; Sharifi AM; Amini MR; Mahmoudian A; Fakhraei H; Aalaa M; Mohajeri-Tehrani MR
    Exp Clin Endocrinol Diabetes; 2013 Jan; 121(1):48-53. PubMed ID: 23329572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Appropriate timing of G-CSF use after mobilization chemotherapy significantly increases the yield of CD34+ cells in autoPBSCT.
    Xu L; Chang C; Li X; Gan W
    J Clin Apher; 2009; 24(6):232-7. PubMed ID: 19899124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis the advantage of autologous mobilized peripheral blood mononuclear cells transplantation on lower limbs ischemia disease].
    Wu LH; Zhang Y; Huang PP; Li SZ; Zhao YX; Long FL; Fu RM; Zheng YL; Liu CH; Liu QG; Li JF; Hu YM; Xu N
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):112-4. PubMed ID: 21429378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral blood progenitor cell mobilization with intermediate-dose cyclophosphamide, sequential granulocyte-macrophage-colony-stimulating factor and granulocyte-colony-stimulating factor, and scheduled commencement of leukapheresis in 225 patients undergoing autologous transplantation.
    Bashey A; Donohue M; Liu L; Medina B; Corringham S; Ihasz A; Carrier E; Castro JE; Holman PR; Xu R; Law P; Ball ED; Lane TA
    Transfusion; 2007 Nov; 47(11):2153-60. PubMed ID: 17958545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.